1. Home
  2. KYN vs WGS Comparison

KYN vs WGS Comparison

Compare KYN & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kayne Anderson Energy Infrastructure Fund Inc.

KYN

Kayne Anderson Energy Infrastructure Fund Inc.

N/A

Current Price

$14.25

Market Cap

2.4B

Sector

Finance

ML Signal

N/A

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

N/A

Current Price

$67.70

Market Cap

2.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
KYN
WGS
Founded
2004
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Retail: Computer Software & Peripheral Equipment
Sector
Finance
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.7B
IPO Year
2004
2020

Fundamental Metrics

Financial Performance
Metric
KYN
WGS
Price
$14.25
$67.70
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $93.50
AVG Volume (30 Days)
316.4K
★ 747.4K
Earning Date
01-01-0001
10-27-2026
Dividend Yield
★ 8.99%
N/A
EPS Growth
N/A
★ 62.37
EPS
★ N/A
N/A
Revenue
N/A
★ $427,539,000.00
Revenue This Year
N/A
$12.70
Revenue Next Year
N/A
$24.31
P/E Ratio
$20.75
★ N/A
Revenue Growth
N/A
★ 39.97
52 Week Low
$11.31
$32.21
52 Week High
$15.17
$170.87

Technical Indicators

Market Signals
Indicator
KYN
WGS
Relative Strength Index (RSI) 50.99 34.41
Support Level $13.59 $56.36
Resistance Level $14.35 $73.21
Average True Range (ATR) 0.24 6.00
MACD 0.04 -2.31
Stochastic Oscillator 79.38 10.43

Price Performance

Historical Comparison
KYN
WGS

About KYN Kayne Anderson Energy Infrastructure Fund Inc.

Kayne Anderson Energy Infrastructure Fund, Inc is a non-diversified, closed-end fund. Its investment objective is to provide a high after-tax total return with an emphasis on making cash distributions to the stockholder. The Company invests in various sectors, which include midstream energy companies, renewable infrastructure companies, and utility companies. The company seeks to achieve its objectives by investing a majority of its total assets in the securities of Energy Infrastructure companies.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: